InsiderTrades

Form 4 for CORT CORCEPT THERAPEUTICS INC

Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0000950170-25-094121 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-07-03 2025-07-01 CORT Lyon Joseph Douglas See Remarks M - OptEx $13.56 +100 10.2K +1.0% +$1,356
DT 2025-07-03 2025-07-01 CORT Lyon Joseph Douglas See Remarks S - Sale+OE $73.51 -100 10.1K -1.0% -$7,351
DT 2025-07-03 2025-07-01 CORT Lyon Joseph Douglas See Remarks M - OptEx $0.00 -100 41.5K -0.2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-07-01 M A 100 $13.56 10,166 D — — (F1) Includes 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
2 Common Common Stock 2025-07-01 S D 100 $73.51 10,066 D — — (F1) Includes 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 215 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
3 Derivative Stock option (right to buy) 2025-07-01 M D 100 $0.00 41,471 D $13.56 · — to 2030-02-07 100 Common Stock (F3) Fully exercisable.